Overcoming Global Regulatory Misalignment to Increase Efficiency in Viral Vector Manufacturing
- Clarifying definitions of raw materials, starting materials, and ancillary components to enable global alignment and consistent quality expectations
- Discussing how industry and regulators can collaborate through pharmacopeial channels to anticipate evolving expectations
- Highlighting gaps and inconsistencies across regional guidance and how standardsetting organizations can help bridge interpretation differences